320 related articles for article (PubMed ID: 30964713)
1.
Brunner K; Samassa F; Sansonetti PJ; Phalipon A
Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
[TBL] [Abstract][Full Text] [Related]
2. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
[TBL] [Abstract][Full Text] [Related]
3. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
Ashida H; Ogawa M; Mimuro H; Sasakawa C
Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
[TBL] [Abstract][Full Text] [Related]
4. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
Phalipon A; Sansonetti PJ
Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832
[TBL] [Abstract][Full Text] [Related]
5.
Schnupf P; Sansonetti PJ
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953429
[No Abstract] [Full Text] [Related]
6. How Do the Virulence Factors of
Mattock E; Blocker AJ
Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
[No Abstract] [Full Text] [Related]
7. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
Ashida H; Sasakawa C
Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
[TBL] [Abstract][Full Text] [Related]
8. Shigella and Enteroinvasive Escherichia Coli.
Belotserkovsky I; Sansonetti PJ
Curr Top Microbiol Immunol; 2018; 416():1-26. PubMed ID: 30218158
[TBL] [Abstract][Full Text] [Related]
9. A new paradigm of bacteria-gut interplay brought through the study of Shigella.
Sasakawa C
Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(3):229-43. PubMed ID: 20228623
[TBL] [Abstract][Full Text] [Related]
10. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
Fernandez MI; Sansonetti PJ
Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
[TBL] [Abstract][Full Text] [Related]
11. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
Killackey SA; Sorbara MT; Girardin SE
Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
[TBL] [Abstract][Full Text] [Related]
12. How Shigella Utilizes Ca(2+) Jagged Edge Signals during Invasion of Epithelial Cells.
Bonnet M; Tran Van Nhieu G
Front Cell Infect Microbiol; 2016; 6():16. PubMed ID: 26904514
[TBL] [Abstract][Full Text] [Related]
13. Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development.
Phalipon A; Sansonetti PJ
Crit Rev Immunol; 2003; 23(5-6):371-401. PubMed ID: 15030306
[TBL] [Abstract][Full Text] [Related]
14. Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins.
de Jong MF; Alto NM
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339461
[TBL] [Abstract][Full Text] [Related]
15. A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
Davis CL; Wahid R; Toapanta FR; Simon JK; Sztein MB
PLoS One; 2018; 13(1):e0189571. PubMed ID: 29304144
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of Shigella: the study of bacteria-host interplay at the intestinal mucosal barriers].
Sasakawa C
Nihon Saikingaku Zasshi; 2012; 67(4):257-68. PubMed ID: 23269180
[TBL] [Abstract][Full Text] [Related]
17. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
[TBL] [Abstract][Full Text] [Related]
18. Shigella are versatile mucosal pathogens that circumvent the host innate immune system.
Ashida H; Ogawa M; Mimuro H; Kobayashi T; Sanada T; Sasakawa C
Curr Opin Immunol; 2011 Aug; 23(4):448-55. PubMed ID: 21763117
[TBL] [Abstract][Full Text] [Related]
19. Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion.
Xu D; Liao C; Zhang B; Tolbert WD; He W; Dai Z; Zhang W; Yuan W; Pazgier M; Liu J; Yu J; Sansonetti PJ; Bevins CL; Shao Y; Lu W
Immunity; 2018 Jun; 48(6):1233-1244.e6. PubMed ID: 29858013
[TBL] [Abstract][Full Text] [Related]
20. New insights into the crosstalk between Shigella and T lymphocytes.
Salgado-Pabón W; Konradt C; Sansonetti PJ; Phalipon A
Trends Microbiol; 2014 Apr; 22(4):192-8. PubMed ID: 24613405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
